Market Tracker

08/21 5:16pm ET

Pluristem Therapeutics Inc (NASDAQ:PSTI)

1.20
Delayed Data
As of 3:59pm ET
 -0.02 / -1.64%
Today’s Change
1.04
Today|||52-Week Range
1.85
-16.08%
Year-to-Date

Today’s Trading

Previous close1.22
Today’s open1.21
Day’s range1.18 - 1.21
Volume94,282
Average volume (3 months)193,763
Market cap$117.5M
Dividend yield--
Data as of 3:59pm ET, 08/21/2017

Growth & Valuation

Earnings growth (last year)+17.14%
Earnings growth (this year)--
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+651.19%
P/E ratioNM
Price/Sales37.16
Price/Book2.57

Competitors

 Today’s
change
Today’s
% change
VSTMVerastem Inc+0.05+1.58%
AXSMAxsome Therapeutics ...0.000.00%
KDMNKadmon Holdings Inc+0.04+1.78%
EVGNEvogene Ltd0.000.00%
Data as of 4:02pm ET, 08/21/2017

Financials

Next reporting dateSeptember 14, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$2.8M
Annual profit (last year)-$23.2M
Net profit margin-816.51%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Co-Chief Executive Officer
Zami Aberman
President, Co-Chief Executive Officer &
Director
Yaky Yanay
Corporate headquarters
Haifa, Haifa

Forecasts